Carisma Therapeutics Ownership
$0.00
36.36%
NYSE, Sep 23, 04:00 pm EDT.
Industry
Carisma Therapeutics Top Shareholders
| # | Holder | Shares | % of Shares Out | Change | Filing Date |
|---|---|---|---|---|---|
| 1 |
Modernatx Inc
|
5.059m | 12.11% | — | Jul 31 2025 |
| 2 |
Longview Innovation Corp
|
2.713m | 6.49% | — | Jul 31 2025 |
| 3 |
Wellington Partners Venture Capital GmbH
|
2.298m | 5.50% | — | Jul 31 2025 |
| 4 |
SymBiosis Capital Management, LLC
|
2.216m | 5.30% | — | Jul 31 2025 |
| 5 |
Abbvie Biotechnology Ltd
|
1.856m | 4.44% | -893.984k | Mar 31 2025 |
|
1
Modernatx Inc
|
12.11%
5.059m
|
|
2
Longview Innovation Corp
|
6.49%
2.713m
|
|
3
Wellington Partners Venture Capital GmbH
|
5.50%
2.298m
|
|
4
SymBiosis Capital Management, LLC
|
5.30%
2.216m
|
|
5
Abbvie Biotechnology Ltd
|
4.44%
1.856m
|
| The largest shareholders show who really holds influence: big institutional owners shape a stock's liquidity, and building or cutting positions can move the price. | |
| The 5 largest shareholders together hold 33.84% of Carisma Therapeutics, with Modernatx Inc the biggest at 12.11%, followed by Longview Innovation Corp (6.49%) and Wellington Partners Venture Capital GmbH (5.50%). |
Recent Carisma Therapeutics Insider Transactions
Powered by
| Date | Insider & Role | Type | Price | Quantity | Volume |
|---|---|---|---|---|---|
| Sep 25 2026 |
John Mitchell
CEO
|
Purchases
|
$182.45 | + 15,000 | $2,736,750 |
| Sep 22 2026 |
Sarah Chen
CFO
|
Sales
|
$179.80 | - 8,500 | $1,528,300 |
| Sep 18 2026 |
Robert Williams
COO
|
Purchases
|
$175.20 | + 12,000 | $2,102,400 |
| Sep 13 2026 |
Emily Rodriguez
Director
|
Sales
|
$181.30 | - 5,200 | $942,760 |
| Sep 07 2026 |
Michael Thompson
SVP Operations
|
Purchases
|
$170.50 | + 20,000 | $3,410,000 |
| Aug 31 2026 |
Lisa Park
General Counsel
|
Sales
|
$177.90 | - 6,800 | $1,209,720 |
| No transactions found for this filter. | |||||
|
John Mitchell
PURCHASES
|
Sep 25 2026
$182.45
|
|
Sarah Chen
SALES
|
Sep 22 2026
$179.80
|
|
Robert Williams
PURCHASES
|
Sep 18 2026
$175.20
|
|
Emily Rodriguez
SALES
|
Sep 13 2026
$181.30
|
|
Michael Thompson
PURCHASES
|
Sep 07 2026
$170.50
|
|
Lisa Park
SALES
|
Aug 31 2026
$177.90
|
| No transactions found for this filter. | |
| Insider transactions show you what executives, directors and major shareholders do with their own stock: people who know the company from the inside. Buys are the most telling signal, because insiders invest their own money. Sells are harder to read, since they can also be driven by taxes, diversification or expiring option programs. |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
